Arvinas, Inc.

Name: Arvinas, Inc. standardized financial statements, quarterly
Creator: Listed

ARVNNasdaqCIK 1655759HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$249.7m, Q2 FY2026

Operating income$164.1m, Q2 FY2026

Net income$169.4m, Q2 FY2026

Arvinas, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	34.6	(43.1)	25.3	76.5	102	59.2	189	22.4	41.9	9.5	15.6	250
Research and development	$m	85.9	95.2	84.3	93.7	86.9	83.3	90.8	68.6	64.7	61.1	60.3	52.6
Operating income	$m	(73.9)	(165)	(83.3)	(48.5)	(60.3)	(58.2)	71.4	(71.5)	(43.8)	(74.6)	(63.8)	164
Interest expense	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	not reported	not reported	not reported	not reported
Income tax	$m	0.0	1.6	0.1	0.2	0.6	(0.4)	0.2	(0.3)	0.3	0.2	0.1	0.2
Net income	$m	(64.0)	(155)	(69.4)	(35.2)	(49.2)	(45.1)	82.9	(61.2)	(35.1)	(67.4)	(57.6)	169
Diluted EPS	$ per share	(1.18)	not reported	(0.97)	(0.49)	(0.68)	not reported	1.14	(0.84)	(0.48)	not reported	(0.90)	2.58
Basic EPS	$ per share	(1.18)	not reported	(0.97)	(0.49)	(0.68)	not reported	1.14	(0.84)	(0.48)	not reported	(0.90)	2.61

Balance sheet

Cash and equivalents$94.3m, Q2 FY2026

Long-term debt$300.0k, Q2 FY2026

Shareholders' equity$562.2m, Q2 FY2026

Arvinas, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	114	312	88.0	155	85.2	101	81.0	115	102	143	87.3	94.3
Current assets	$m	1,033	1,280	1,190	1,257	1,150	1,067	980	890	826	701	631	652
Total assets	$m	1,058	1,305	1,213	1,280	1,167	1,091	1,001	909	844	718	648	675
Current liabilities	$m	317	257	241	347	276	230	214	158	145	143	116	82.5
Total liabilities	$m	601	645	603	679	581	530	341	300	280	284	261	113
Long-term debt	$m	0.8	0.8	0.7	0.7	0.6	0.6	0.5	0.5	0.4	0.4	0.3	0.3
Current portion of debt	$m	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Shareholders' equity	$m	457	660	610	600	586	562	660	609	564	434	387	562

Cash flow

Operating cash flow−$48.3m, Q2 FY2026

Capital expenditure$200.0k, Q2 FY2026

Share repurchases$74.1m, Q4 FY2025

Arvinas, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	(84.8)	(83.1)	(97.5)	50.3	(128)	(84.1)	(88.9)	(95.4)	(59.1)	(30.4)	(69.2)	(48.3)
Capital expenditure	$m	1.1	0.1	0.1	0.7	0.7	0.3	0.4	1.2	0.1	0.2	1.3	0.2
Share repurchases	$m	not reported	not reported	not reported	not reported	not reported	0.0	not reported	not reported	not reported	74.1	not reported	not reported

Diluted shares (weighted)65.70m, Q2 FY2026

Arvinas, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	53.2	53.3	53.4	54.1	71.7	71.9	72.1	72.7	73.0	73.2	64.0	65.7

Shares outstanding: 65.39m at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.